Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study

Fig. 2

Hematologic parameters compared between both groups. Values are measured on day 0 of cycle 1 immediately before the chemotherapy infusion, on day 7 of cycle 1–5 combined and day 21 of cycle 1–5 combined. * P value <0.05. STF; short-term fasting, Reference values: erythrocytes 4-5*1012/L; thrombocytes 150-400*109/L

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us